Feasibility of a new mind and body treatment for pediatric functional seizures
Official title: A Multi-site Feasibility Clinical Trial of Retraining and Control Therapy (ReACT), a Mind and Body Treatment for Pediatric Functional Seizures
Run by University of Alabama at Birmingham · NCT05819268 · Data updated 2026-11-12
This study is testing if two different treatments for kids with functional seizures work well enough to be used in a larger trial.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 11 Years to 18 Years |
| Sex | All |
| Enrollment | 108 (estimated) |
| Sponsor | University of Alabama at Birmingham Academic / other |
| Locations | 1 site (Birmingham, Alabama) |
| Status | Recruiting |
| Started | March 18, 2024 |
| Main results expected | December 2026 |
| Study ends | August 2027 |
| Registry record updated | March 17, 2026 |
| Trial ID | NCT05819268 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adolescents aged 11-18 diagnosed with functional seizures who have internet access for telehealth sessions.
✕Probably not a fit
Patients with comorbid epilepsy or those experiencing fewer than four functional seizures per month may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study assesses the feasibility of conducting a future large-scale trial comparing two treatments for pediatric functional seizures in adolescents aged 11-18. Participants will be randomized to receive either Retraining and Control Therapy (ReACT) or Competent Adulthood Transition with Cognitive Behavioral, Humanistic, and Interpersonal Training (CATCH-IT). The study will measure recruitment feasibility, treatment acceptability, and participant retention through follow-up visits and questionnaires. The interventions will be delivered through a combination of in-person and telehealth sessions over a period of 12 weeks.
Why it matters
Potential benefit: If successful, this study could lead to effective treatment options for children suffering from functional seizures.
How similar studies have gone: While similar approaches have been explored, this specific combination of treatments for pediatric functional seizures is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Males and females ages 11-18 * Diagnosis of functional seizures * Internet access for telehealth sessions and CATCH-IT Exclusion Criteria: * Comorbid epilepsy * Less than 4 functional seizures per month * Other paroxysmal nonepileptic events (e.g. hypoxic-ischemic phenomena, sleep disorders or migraine-associated disorders) * Participation in other therapy * Severe intellectual disability * Severe mental illness (active delusions/hallucinations)
Where it's running
-
University of Alabama at Birmingham
Birmingham, Alabama, United States Recruiting
Study contacts
- Study coordinator: Aaron Fobian, PhD
- Email: afobian@uabmc.edu
- Phone: 205-934-2241
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Accelerated magnetic brain stimulation for seizure-type functional neurologic disorder
This trial will try a shortened, intensified course of magnetic brain stimulation over the left frontal cortex to see if it reduces functional (non-epileptic) seizures in adults.
-
Retraining and Control Therapy for adults with non-epileptic seizures
This study is testing a new therapy called Retraining and Control Therapy to see if it can help adults with non-epileptic seizures feel more in control and reduce their worries about their symptoms.
-
Creating a treatment program for functional neurological disorder
This study is trying to create a new treatment plan for people with functional neurological disorder by bringing together different types of therapy to see if it helps both kids and adults feel better.
-
Therapy to improve control and reduce symptoms in children with non-epileptic seizures
This study is testing a new therapy called ReACT to see if it can help children aged 11-18 with non-epileptic seizures feel more in control and reduce their symptoms.
-
Therapy to improve control and reduce symptoms in children with non-epileptic seizures
This study is testing a new therapy called ReACT to see if it can help children aged 9-18 with non-epileptic seizures feel more in control and reduce their symptoms.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.